🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

Recruitingn/aAges 50 Years - 80 YearsAllFayoum University
NCT06520891 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * we include patients established ischemic heart failure seen by a primary care provider to diagnose ischemic heart disease, * They assessed the use of statin with SGLT2i. Exclusion Criteria: * We exclude patients with 1. liver dysfunction. 2. renal dysfunction. 3. fungal infection. 4. coagulation disorder. 5. Pts using drugs that interact with SGLT2i. 6. patients that will refuse to be enrolled in the Study or refuse to write informed consent.
💊

What it tests

  • Statin and SGLT2i
📍

Where

1 site
Asmaa mohamed abdelkader
Al Fayyum, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy